Search

everythinglearnresearchcommunity

for

Search:↓

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Neuregulin3 affects cell development in the skin and mammary glands.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Blood pressure drugs can cause skin lupus, but it improves after stopping the drug. The glycoprotein D vaccine works against genital herpes in some women, and the HPV-16 vaccine reduces HPV-16 infection and related diseases. More frequent light therapy clears psoriasis faster. A cream called imiquimod effectively treats a type of skin cancer. Iron supplements don't necessarily help with chronic hair loss in women.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

Blocking TSLP reduces skin inflammation and cell overgrowth in psoriasis.

Li2CO3 improved skin disease in a mouse model of Focal Dermal Hypoplasia without toxicity.

Women with PCOS are at higher risk for gum disease, and managing shared risk factors can help both conditions.

Type 3 Innate Lymphoid Cells help maintain skin health and balance, and are involved in skin diseases and healing.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

Monocytes might be linked to hair loss after COVID-19.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Non-surgical procedures can help reduce wrinkles and stimulate skin repair by understanding skin aging at the molecular level.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Nanoformulations improve luteolin's effectiveness as a cancer treatment.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

UV radiation can help sterilize wounds and promote healing but requires careful use to avoid damaging cells.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Certain medications, including some immune drugs, contraceptives, and hair loss treatments, are often linked to hair loss.